[HTML][HTML] Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol

MT Neary, LM Mulder, PS Kowalski… - Journal of Controlled …, 2024 - Elsevier
In the past decade RNA-based therapies such as small interfering RNA (siRNA) and
messenger RNA (mRNA) have emerged as new and ground-breaking therapeutic agents for …

[HTML][HTML] Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape

X Li, J Qi, J Wang, W Hu, W Zhou, Y Wang, T Li - Theranostics, 2024 - ncbi.nlm.nih.gov
The mRNA vaccine, a groundbreaking advancement in the field of immunology, has
garnered international recognition by being awarded the prestigious Nobel Prize, which has …

Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice

Y Wang, J Zhang, Y Liu, X Yue, K Han, Z Kong… - Science …, 2024 - science.org
The stemness loss–associated dysregeneration of impaired alveolar type 2 epithelial (AT2)
cells abolishes the reversible therapy of idiopathic pulmonary fibrosis (IPF). We here report …

Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation

K Su, L Shi, T Sheng, X Yan, L Lin, C Meng… - Nature …, 2024 - nature.com
Fully targeted mRNA therapeutics necessitate simultaneous organ-specific accumulation
and effective translation. Despite some progress, delivery systems are still unable to fully …

Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation

J Kim, A Jozić, E Bloom, B Jones, M Marra… - ACS …, 2024 - ACS Publications
Leveraging the extensive surface area of the lungs for gene therapy, the inhalation route
offers distinct advantages for delivery. Clinical nebulizers that employ vibrating mesh …

Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles

DO Popoola, Z Cao, Y Men, X Li, M Viapiano… - Nano Letters, 2024 - ACS Publications
Among various mRNA carrier systems, lipid nanoparticles (LNPs) stand out as the most
clinically advanced. While current clinical trials of mRNA/LNP therapeutics mainly address …

Branching in Poly (amine-co-ester) Polyplexes Impacts mRNA transfection

K Shin, HW Suh, A Suberi, CH Whang, M Ene… - Biomaterials, 2024 - Elsevier
Branching is a key structural parameter of polymers, which can have profound impacts on
physicochemical properties. It has been demonstrated that branching is a modulating factor …

mRNA Vaccines Contribute to Innate and Adaptive Immunity to Enhance Immune Response In Vivo

Q Cao, H Fang, H Tian - Biomaterials, 2024 - Elsevier
Messenger RNA (mRNA) therapeutics have been widely employed as strategies for the
treatment and prevention of diseases. Amid the global outbreak of COVID-19, mRNA …

Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery

G Zeng, Z He, H Yang, Z Gao, X Ge, L Liu… - … Applied Materials & …, 2024 - ACS Publications
Much of current clinical interest has focused on mRNA therapeutics for the treatment of lung-
associated diseases, such as infections, genetic disorders, and cancers. However, the safe …

Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery

Y Zhao, ZM Wang, D Song, M Chen, Q Xu - Current Opinion in Chemical …, 2024 - Elsevier
This review introduces the typical delivery process of messenger RNA (mRNA)
nanomedicines and concludes that the delivery involves a at least four-step SCER cascade …